A new study led by Pierre Close's team (GIGA, Laboratory of Cancer Signaling, and WELRI Investigator) reveals how subtly disrupting the way tumors produce their proteins can trigger a potent antitumor ...

Borrowing a cancer cell’s disguise, scientists shielded insulin-producing cells from attack by the immune system, a breakthrough that could pave the way for targeted type 1 diabetes treatments without ...

For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only ...

A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.

Lymph nodes, considered the command centers of our immune system, often get swollen and stiff when fighting infection. Now, a UC Berkeley-led team of researchers has discovered that this mechanical ...

Using animal models, researchers uncovered how cervical and throat cancers linked to the human papillomavirus evade the immune system, opening the door to new treatment. The most common cancer-causing ...

The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecules. Cytotoxic T cells (CTLs), also known as “killer” T cells, play a central ...

Dormant lung cancer cells change their shape from spindle shaped (above) to round (below), which helps protect them from the body's immune defenders. Cancer cells that have broken away from a primary ...

Immune evasion is a biological process by which pathogens, tumor cells, or other aberrant cells avoid detection, recognition, or elimination by the host immune system, thereby promoting persistence ...

A study published in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can ...

Cancer spreads (metastasizes) when tumor cells shed from a primary solid tumor (for example, in the breast) and embed in ...